Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081293 | SCV000113201 | benign | not specified | 2016-03-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000081293 | SCV000517680 | benign | not specified | 2015-12-02 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001514167 | SCV001721948 | benign | Methylmalonic acidemia with homocystinuria, type cblX | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001514167 | SCV001934092 | benign | Methylmalonic acidemia with homocystinuria, type cblX | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004713243 | SCV005275024 | benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000081293 | SCV000151383 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. |